Antidiabetic drugs, glycemic control and risk of benign prostatic hyperplasia.

Lotta H NygårdKirsi TalalaKimmo TaariTeuvo L J TammelaAnssi AuvinenTeemu J Murtola

Published in: The Prostate (2022)

Diabetic BGL and antidiabetic medication use, especially insulin, are associated with an elevated risk of BPH surgery compared to nondiabetic men. These findings support the roles of insulin use and untreated hyperglycemia as possible BPH risk factors.

Keyphrases

benign prostatic hyperplasia
glycemic control
type diabetes
lower urinary tract symptoms
risk factors
blood glucose
minimally invasive
weight loss
coronary artery bypass
insulin resistance
metabolic syndrome
middle aged
wound healing
coronary artery disease
skeletal muscle